Sphera Funds Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Sphera Funds Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-112,500	Closed	-$3.69M	–	131
2016 Q3	$3.69M	Hold	112,500	–	–	0.6%	43
2016 Q2	$2.81M	Buy	112,500 +50,000	+80%	+$1.35M	0.73%	43
2016 Q1	$1.53M	Sell	62,500 -50,000	-44%	-$1.16M	0.33%	70
2015 Q4	$3.72M	Sell	112,500 -12,500	-10%	-$423K	0.54%	34
2015 Q3	$4.09M	Hold	125,000	–	–	0.52%	37
2015 Q2	$6.62M	Sell	125,000 -25,000	-17%	-$909K	0.65%	28
2015 Q1	$4.33M	Buy	150,000 +50,000	+50%	+$1.37M	0.45%	55
2014 Q4	$2.91M	Sell	100,000 -50,000	-33%	-$897K	0.5%	68
2014 Q3	$1.9M	Buy	+150,000	New	+$2.27M	0.24%	93

Other funds holding ALDR

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return